Literature DB >> 17991291

Detection of enteroviruses in the intestine of type 1 diabetic patients.

M Oikarinen1, S Tauriainen, T Honkanen, S Oikarinen, K Vuori, K Kaukinen, I Rantala, M Mäki, H Hyöty.   

Abstract

Enterovirus infections have been diagnosed more frequently in type 1 diabetic patients than in the healthy population, and enteroviruses have also been found in the pancreas of diabetic patients. Primary replication of the virus occurs in the gut, but there are no previous studies evaluating possible presence of virus in the intestine of diabetic patients. The purpose of this study was to investigate if enteroviruses can be found in small intestinal tissue of type 1 diabetic patients. Formalin-fixed, paraffin-embedded upper intestinal biopsy samples were analysed for the presence of enterovirus using in situ hybridization and immunohistochemistry. Enterovirus was detected by in situ hybridization in six (50%) of the type 1 diabetic patients (n = 12) but in none of the control subjects (n = 10, P = 0.015). Immunohistochemistry identified enterovirus in nine (75%) of the patients and one (10%) control subject (P = 0.004). The presence of the virus was confirmed by reverse transcription-polymerase chain reaction in one of the four patients from whom a frozen and unfixed sample was available. Intestinal morphology was normal in all study subjects. The results suggest that a substantial proportion of type 1 diabetic patients have an ongoing enterovirus infection in gut mucosa, possibly reflecting persistent enterovirus infection. This observation opens new avenues for further studies on the possible role of enteroviruses in human type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991291      PMCID: PMC2276929          DOI: 10.1111/j.1365-2249.2007.03529.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets.

Authors:  Arno Hänninen; Rita Nurmela; Mikael Maksimow; Jarkko Heino; Sirpa Jalkanen; Christian Kurts
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment.

Authors:  K Sayama; A Imagawa; K Okita; S Uno; M Moriwaki; J Kozawa; H Iwahashi; K Yamagata; S Tamura; Y Matsuzawa; T Hanafusa; J Miyagawa; I Shimomura
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

Review 3.  Putative environmental factors in Type 1 diabetes.

Authors:  H K Akerblom; M Knip
Journal:  Diabetes Metab Rev       Date:  1998-03

4.  Diagnosis of enterovirus and rhinovirus infections by RT-PCR and time-resolved fluorometry with lanthanide chelate labeled probes.

Authors:  M Lönnrot; M Sjöroos; K Salminen; M Maaronen; T Hyypiä; H Hyöty
Journal:  J Med Virol       Date:  1999-11       Impact factor: 2.327

5.  Increased intestinal permeability precedes clinical onset of type 1 diabetes.

Authors:  E Bosi; L Molteni; M G Radaelli; L Folini; I Fermo; E Bazzigaluppi; L Piemonti; M R Pastore; R Paroni
Journal:  Diabetologia       Date:  2006-10-07       Impact factor: 10.122

Review 6.  Gut and the induction of immune tolerance in type 1 diabetes.

Authors:  O Vaarala
Journal:  Diabetes Metab Res Rev       Date:  1999 Sep-Oct       Impact factor: 4.876

7.  Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study.

Authors:  Kimmo Salminen; Karita Sadeharju; Maria Lönnrot; Paula Vähäsalo; Antti Kupila; Sari Korhonen; Jorma Ilonen; Olli Simell; Mikael Knip; Heikki Hyöty
Journal:  J Med Virol       Date:  2003-01       Impact factor: 2.327

8.  A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region.

Authors:  Deborah J Smyth; Jason D Cooper; Rebecca Bailey; Sarah Field; Oliver Burren; Luc J Smink; Cristian Guja; Constantin Ionescu-Tirgoviste; Barry Widmer; David B Dunger; David A Savage; Neil M Walker; David G Clayton; John A Todd
Journal:  Nat Genet       Date:  2006-05-14       Impact factor: 38.330

Review 9.  Enterovirus infections and type 1 diabetes.

Authors:  Heikki Hyöty
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

10.  Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.

Authors:  Francesco Dotta; Stefano Censini; Astrid G S van Halteren; Lorella Marselli; Matilde Masini; Sabrina Dionisi; Franco Mosca; Ugo Boggi; Andrea Onetti Muda; Stefano Del Prato; John F Elliott; Antonello Covacci; Rino Rappuoli; Bart O Roep; Piero Marchetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

View more
  34 in total

Review 1.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes.

Authors:  K Lind; M H Hühn; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

2.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: viruses, autoimmunity and immunoregulation.

Authors:  C M Filippi; M G von Herrath
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 3.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

Review 4.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 5.  Virus infections and type 1 diabetes risk.

Authors:  Merja Roivainen; Karin Klingel
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

6.  Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice.

Authors:  A S Lee; D L Gibson; Y Zhang; H P Sham; B A Vallance; J P Dutz
Journal:  Diabetologia       Date:  2009-12-13       Impact factor: 10.122

7.  Analysis of pancreas tissue in a child positive for islet cell antibodies.

Authors:  M Oikarinen; S Tauriainen; T Honkanen; K Vuori; P Karhunen; C Vasama-Nolvi; S Oikarinen; C Verbeke; G E Blair; I Rantala; J Ilonen; O Simell; M Knip; H Hyöty
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

8.  Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.

Authors:  Sarah J Richardson; Pia Leete; Shalinee Dhayal; Mark A Russell; Maarit Oikarinen; Jutta E Laiho; Emma Svedin; Katharina Lind; Therese Rosenling; Nora Chapman; Adrian J Bone; Alan K Foulis; Gun Frisk; Malin Flodstrom-Tullberg; Didier Hober; Heikki Hyoty; Noel G Morgan
Journal:  Diabetologia       Date:  2013-11-05       Impact factor: 10.122

9.  Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice.

Authors:  P G Larsson; T Lakshmikanth; E Svedin; C King; M Flodström-Tullberg
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

10.  Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells.

Authors:  Barbara M Schulte; Matthijs Kramer; Marleen Ansems; Kjerstin H W Lanke; Neeltje van Doremalen; Jon D Piganelli; Rita Bottino; Massimo Trucco; Jochem M D Galama; Gosse J Adema; Frank J M van Kuppeveld
Journal:  Diabetes       Date:  2010-01-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.